Intellectual Property India Publishes Patent Application for 'Novel Peptide Based Immune-Checkpoint Blockerfor Breast Cancer Treatment' Filed by Indian Institute Of Science Education And Research

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202431033327 A) filed by Indian Institute Of Science Education And Research, Kolkata, West Bengal, on April 26, 2024, for 'novel peptide based immune-checkpoint blockerfor breast cancer treatment.'

Inventor(s) include Sinha Roy, Rituparna; Tripathi, Archana; Chatterjee, Ananya; Gurung, Arun Bahadur; and Mallick, Argha Mario.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "There is provided an immune check point blocker protease stable peptide for breast cancer treatment selected from the group consisting of peptides having SEQ ID NO. 1, SEQ ID. ...